Chaoliu Dai
Reproducibility track record
1
assessed papers
45/100
mean reproducibility
0
reproduced (C1–C2)
1
flagged
22
total citations
flag rate:
100%
(1/1)
The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.
Authorship role
first author: 0
last author: 0
Topics
Funders
—
Frequent co-authors
Lisha Sun 1Xinbo Qiao 1Guanglei Chen 1Taofei Zeng 1Hui Chen 1Na Li 1Feng Xu 1Junqi Wang 1Qingtian Ma 1
Institutions
China Medical University 1Second Affiliated Hospital of Dalian Medical University 1
Geography (author institutions)
CN 1
Co-author network
Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.
How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.
Assessed papers (1)
Complete publication record (75)
Request a reproduction →1 assessed by us (0 reproduced) · 74 not yet assessed — every PubMed paper on record, linked below.
-
not yet assessed
-
not yet assessed
-
China Liver Cancer Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2024 Edition) ↗Liver Cancer · 2025 · PMID 41063733not yet assessed
-
c-Rel drives pancreatic cancer metastasis through fibronectin-integrin signaling-induced isolation stress resistance and EMT ↗Molecular Cancer · 2025 · PMID 41398670not yet assessed
-
A Survey of Clinical Practices for Hepatocellular Carcinoma Among Experts at Tertiary Hospitals in China From 2020 to 2021 ↗Cancer Innovation · 2025 · PMID 40196745not yet assessed
-
Chinese expert consensus on conversion and perioperative therapy of primary liver cancer (2024 edition) ↗HepatoBiliary Surgery and Nutrition · 2025 · PMID 42273581not yet assessed
-
Development and validation of a new prognostic tool for hepatocellular carcinoma undergoing resection: The Weighted Alpha-Fetoprotein Tumor Burden Score (WATS) ↗European Journal of Surgical Oncology · 2025 · PMID 40009918not yet assessed
-
c-Rel drives pancreatic cancer metastasis through Fibronectin-Integrin signaling-induced isolation stress resistance and EMT activation ↗bioRxiv (Cold Spring Harbor Laboratory) · 2025 · PMID 39975057not yet assessed
-
Impact of three-dimensional reconstruction visualization technology on short-term and long-term outcomes after hepatectomy in patients with hepatocellular carcinoma: a propensity‐score‐matched and inverse probability of treatment‐weighted multicenter study ↗International Journal of Surgery · 2024 · PMID 38241321not yet assessed
-
Chinese expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition) ↗BioScience Trends · 2024 · PMID 39721704not yet assessed
-
HHLA2 promotes hepatoma cell proliferation, migration, and invasion via SPP1/PI3K/AKT signaling pathway ↗Molecular Carcinogenesis · 2024 · PMID 38578157not yet assessed
-
The tumor burden score may be a discriminator in microwave ablation versus liver resection for hepatocellular carcinoma within the Milan criteria: a propensity score matching and inverse probability of treatment weighting study ↗Frontiers in Oncology · 2024 · PMID 38434686not yet assessed
-
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial ↗The Lancet · 2023 · PMID 37871608not yet assessed
-
Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition) ↗Liver Cancer · 2023 · PMID 37901768not yet assessed
-
Potential Treatment Strategies for Hepatocellular Carcinoma Cell Sensitization to Sorafenib ↗Journal of Hepatocellular Carcinoma · 2023 · PMID 36815094not yet assessed
-
Artificial Downregulation of Ribosomal Protein L34 Restricts the Proliferation and Metastasis of Colorectal Cancer by Suppressing the <i>JAK2/STAT3</i> Signaling Pathway ↗Human Gene Therapy · 2023 · PMID 37427415not yet assessed
-
1012P First-in-human study of ABSK-011, a novel, highly selective fibroblast growth factor receptor (FGFR) 4 inhibitor for treating advanced hepatocellular carcinoma (HCC) with FGF19 overexpression ↗Annals of Oncology · 2023not yet assessed
-
CgB promotes EMT and stemness via MAPK pathway in colonic neuroendocrine carcinoma. ↗PubMed · 2023 · PMID 37168358not yet assessed
-
Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition) ↗HepatoBiliary Surgery and Nutrition · 2022 · PMID 35464283not yet assessed
-
Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition) ↗Liver Cancer · 2022 · PMID 35978596not yet assessed
-
AKR1C3-dependent lipid droplet formation confers hepatocellular carcinoma cell adaptability to targeted therapy ↗Theranostics · 2022 · PMID 36451864not yet assessed
-
NUSAP1 Could be a Potential Target for Preventing NAFLD Progression to Liver Cancer⚑Frontiers in Pharmacology · 2022 · PMID 35431924L1 45/100 ⚑
-
Chinese Expert Consensus on Immunotherapy for Hepatocellular Carcinoma (2021 Edition) ↗Liver Cancer · 2022 · PMID 36589726not yet assessed
-
Prognostic value of combined inflammatory and nutritional biomarkers in HCC within the Milan criteria after hepatectomy ↗Frontiers in Oncology · 2022 · PMID 36132141not yet assessed
-
MUC2 and related bacterial factors: Therapeutic targets for ulcerative colitis ↗EBioMedicine · 2021 · PMID 34902790not yet assessed
-
The CD112R/CD112 axis: a breakthrough in cancer immunotherapy ↗Journal of Experimental & Clinical Cancer Research · 2021 · PMID 34507594not yet assessed
-
Therapeutic efficacy of microwave coagulation versus liver resection for hepatocellular carcinoma within the Milan criteria: A propensity score matching analysis ↗European Journal of Surgical Oncology · 2021 · PMID 34509336not yet assessed
-
not yet assessed
-
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition) ↗Liver Cancer · 2020 · PMID 33442540not yet assessed
-
Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy ↗Signal Transduction and Targeted Therapy · 2020 · PMID 33122640not yet assessed
-
GNAS promotes inflammation-related hepatocellular carcinoma progression by promoting STAT3 activation ↗Cellular & Molecular Biology Letters · 2020 · PMID 32123532not yet assessed
-
<p>Overexpression of COL24A1 in Hepatocellular Carcinoma Predicts Poor Prognosis: A Study Based on Multiple Databases, Clinical Samples and Cell Lines</p> ↗OncoTargets and Therapy · 2020 · PMID 32308416not yet assessed
-
Surgical and local treatment of hepatic metastasis in pancreatic ductal adenocarcinoma: recent advances and future prospects ↗Therapeutic Advances in Medical Oncology · 2020 · PMID 32636941not yet assessed
-
Ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma adjacent to large vessels: a propensity score matching analysis ↗International Journal of Hyperthermia · 2020 · PMID 32781862not yet assessed
-
[Efficacy of three-dimensional visualization technology in the precision diagnosis and treatment for primary liver cancer: a retrospective multicenter study of 1 665 cases in China]. ↗PubMed · 2020 · PMID 32393005not yet assessed
-
Long Noncoding RNA SNHG15 Serves as an Oncogene and Predicts Poor Prognosis in Epithelial Ovarian Cancer [Expression of Concern]DOAJ (DOAJ: Directory of Open Access Journals) · 2020not yet assessed
-
Inflammation and Inflammatory Cytokine Contribute to the Initiation and Development of Ulcerative Colitis and Its Associated Cancer ↗Inflammatory Bowel Diseases · 2019 · PMID 31287863not yet assessed
-
Mitochondrial metabolic reprogramming: An important player in liver cancer progression ↗Cancer Letters · 2019 · PMID 31783085not yet assessed
-
Beneficial impact of microwave ablation-assisted laparoscopic hepatectomy in cirrhotic hepatocellular carcinoma patients: a propensity score matching analysis ↗International Journal of Hyperthermia · 2019 · PMID 31066585not yet assessed
-
Albumin-bilirubin score versus Child-Pugh score as predictors of posthepatectomy liver failure in hepatocellular carcinoma patients ↗Zhonghua putong waike zazhi · 2019not yet assessed
-
Immune checkpoint therapy in liver cancer ↗Journal of Experimental & Clinical Cancer Research · 2018 · PMID 29843754not yet assessed
-
Effect of Huaier granule on recurrence after curative resection of HCC: a multicentre, randomised clinical trial ↗Gut · 2018 · PMID 29802174not yet assessed
-
Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus ↗HepatoBiliary Surgery and Nutrition · 2018 · PMID 30498711not yet assessed
-
Relationship between epithelial-to-mesenchymal transition and the inflammatory microenvironment of hepatocellular carcinoma ↗Journal of Experimental & Clinical Cancer Research · 2018 · PMID 30157906not yet assessed
-
Current status of surgical treatment of colorectal liver metastases ↗World Journal of Clinical Cases · 2018 · PMID 30510936not yet assessed
-
The prognostic factors between different viral etiologies among advanced hepatocellular carcinoma patients receiving sorafenib treatment ↗Journal of Hepatology · 2018not yet assessed
-
The advantages and disadvantages of laparoscopic anatomic hepatectomy ↗Chin J Oper Proc Gen Surg(Electronic Edition) · 2018not yet assessed
-
Lipopolysaccharide stimulates endogenous β-glucuronidase via PKC/NF-κB/c-myc signaling cascade: a possible factor in hepatolithiasis formation ↗Molecular and Cellular Biochemistry · 2017 · PMID 29188532not yet assessed
-
Expression of hypoxia inducible factor-1α and its correlation with phosphoenolpyruvate carboxykinase after portal vein ligation in rats ↗Life Sciences · 2017 · PMID 28958473not yet assessed
-
Clinical analysis of microwave ablation assisted laparoscopic hepatectomy for hepatocellular carcinoma ↗Zhonghua putong waike zazhi · 2017not yet assessed
-
Diagnosis and treatment of hepatic inflammatory myofibroblastic tumor after cesarean section ↗Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi · 2017not yet assessed
-
Armc8 regulates the invasive ability of hepatocellular carcinoma through E-cadherin/catenin complex ↗Tumor Biology · 2016 · PMID 26944057not yet assessed
-
Use of hepatic blood inflow occlusion and hemihepatic artery retention in liver resection for hepatocellular carcinoma ↗Translational Cancer Research · 2016not yet assessed
-
Use of hepatic blood inflow occlusion and hemihepatic artery retention in liver resection for hepatocellular carcinoma ↗Translational Cancer Research · 2016not yet assessed
-
High serum microRNA-122 level is independently associated with higher overall survival rate in hepatocellular carcinoma patients ↗Tumor Biology · 2015 · PMID 25636448not yet assessed
-
Genetic variations in the TERT and CLPTM1L gene region and gastrointestinal stromal tumors risk ↗Oncotarget · 2015 · PMID 26372813not yet assessed
-
Overexpression of δ-catenin is associated with a malignant phenotype and poor prognosis in colorectal cancer ↗Molecular Medicine Reports · 2015 · PMID 26062780not yet assessed
-
An Updated Meta-Analysis of Randomized Controlled Trials Assessing the Effect of Sorafenib in Advanced Hepatocellular Carcinoma ↗PLoS ONE · 2014 · PMID 25460347not yet assessed
-
Individulized treatment of synchronous colorectal liver metastases ↗Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi · 2014not yet assessed
-
The role of hepatocyte nuclear factor 4alpha in metastatic tumor formation of hepatocellular carcinoma and its close relationship with the mesenchymal–epithelial transition markers ↗BMC Cancer · 2013 · PMID 24059685not yet assessed
-
Delta-catenin promotes the proliferation and invasion of colorectal cancer cells by binding to E-cadherin in a competitive manner with p120 catenin ↗Targeted Oncology · 2013 · PMID 23423910not yet assessed
-
Pylorus-preserving pancreaticoduodenectomy with technique modifications ↗Pancreatology · 2013not yet assessed
-
Solid pseudopapillary tumors of the pancreas: An updated experience in single center ↗Pancreatology · 2013not yet assessed
-
Nanog: A Potential Biomarker for Liver Metastasis of Colorectal Cancer ↗Digestive Diseases and Sciences · 2012 · PMID 22562535not yet assessed
-
Clinical characteristics of the primary hepatic malignant fibrous histiocytoma in China: case report and review of the literature ↗World Journal of Surgical Oncology · 2012 · PMID 22221822not yet assessed
-
Evaluation of surgical treatments for hepatolithiasis ↗World Chinese Journal of Digestology · 2012not yet assessed
-
Mechanism of the Mesenchymal–Epithelial Transition and Its Relationship with Metastatic Tumor Formation ↗Molecular Cancer Research · 2011 · PMID 21840933not yet assessed
-
434 IMPROVEMENT OF GLUCOSE ABNORMALITIES IN PREDIABETIC CHRONIC HEPATITIS C PATIENTS AFTER PEGINTERFERON-ALPHA PLUS RIBAVIRIN THERAPY ↗Journal of Hepatology · 2011not yet assessed
-
1053 ASSOCIATION BETWEEN DIABETES MELLITUS, HEPATIC STEATOSIS AND FIBROSIS IN CHRONIC HEPATITIS C PATIENTS IN TAIWAN ↗Journal of Hepatology · 2010not yet assessed
-
[Patterns of hepatic cells death during hepatic ischemia/reperfusion injury in cirrhotic rats]. ↗PubMed · 2008 · PMID 18795620not yet assessed
-
[Resection of centrally located primary liver cancer]. ↗PubMed · 2008 · PMID 18795621not yet assessed
-
MEDIAN PANCREATECTOMY FOR BENIGN OR LOW-GRADE MALIGNANT TUMORS ↗Pancreas · 2007not yet assessed
-
Effects of Shen Fu Injection on Activity of ATPase in Hepatic Ischemia Reperfusion Injury in RatsZhongguo yaofang · 2007not yet assessed
-
Changed clinical aspects of primary liver cancer in China during the past 30 years. ↗PubMed · 2004 · PMID 15138108not yet assessed
-
[Effects of blood transfusion on cellular immuno-function in patients with laryngeal carcinoma]. ↗PubMed · 2001 · PMID 12541675not yet assessed
Full bibliography from OpenAlex; reproducibility verdicts matched by PMID.
Author attribution follows OpenAlex disambiguation, which is imperfect — a researcher's papers can be split across profiles or mixed with a namesake.
Merged across profiles sharing this ORCID where present. See every “Dai C” paper on PubMed ↗